Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -3.50 is 51% above its 5-year average of -7.15, near the high end of its 5-year range (-21.92–-2.21).
16.17% above its 12-month average of -4.18.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.31.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 9 comparable quarters.
EARNINGS PER SHARE (EPS)
-3.50
EARNINGS PER SHARE (EPS) AVG TTM
-4.18
EARNINGS PER SHARE (EPS) AVG 3Y
-3.30
EARNINGS PER SHARE (EPS) AVG 5Y
-7.15
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+16.17%
CURRENT VS 3Y AVG
-5.98%
CURRENT VS 5Y AVG
+51.01%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
OnKure Therapeutics, Inc.
Market Cap
$99.62M
Earnings Per Share (EPS)
-3.50
TTM Avg
-4.18
3Y Avg
-3.30
5Y Avg
-7.15
Market Cap
$97.94M
Earnings Per Share (EPS)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$97.90M
Earnings Per Share (EPS)
-1.48
TTM Avg
-3.50
3Y Avg
-21.30
5Y Avg
-30.60
Market Cap
$101.36M
Earnings Per Share (EPS)
0.27
TTM Avg
-0.10
3Y Avg
-0.20
5Y Avg
0.10
Market Cap
$97.14M
Earnings Per Share (EPS)
-10.01
TTM Avg
-10.93
3Y Avg
-75.63
5Y Avg
-58.09
Market Cap
$102.75M
Earnings Per Share (EPS)
-0.30
TTM Avg
-0.36
3Y Avg
-0.38
5Y Avg
-0.40
Market Cap
$103.14M
Earnings Per Share (EPS)
-0.74
TTM Avg
-0.44
3Y Avg
-1.32
5Y Avg
-1.80
Market Cap
$95.14M
Earnings Per Share (EPS)
-0.69
TTM Avg
-0.71
3Y Avg
-1.04
5Y Avg
-1.15
Market Cap
$104.26M
Earnings Per Share (EPS)
-1.60
TTM Avg
-2.42
3Y Avg
-1.68
5Y Avg
-1.45
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OnKure Therapeutics, Inc. (OKUR) | $99.62M | -3.50 | -4.18 | -3.30 | -7.15 |
| Conexeu Sciences Inc. (CNXU)vs › | $97.94M | N/A | N/A | N/A | N/A |
| PolyPid Ltd. (PYPD)vs › | $97.90M | -1.48 | -3.50 | -21.30 | -30.60 |
| The Joint Corp. (JYNT)vs › | $101.36M | 0.27 | -0.10 | -0.20 | 0.10 |
| Korro Bio, Inc. (KRRO)vs › | $97.14M | -10.01 | -10.93 | -75.63 | -58.09 |
| Anixa Biosciences, Inc. (ANIX)vs › | $102.75M | -0.30 | -0.36 | -0.38 | -0.40 |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $103.14M | -0.74 | -0.44 | -1.32 | -1.80 |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $95.14M | -0.69 | -0.71 | -1.04 | -1.15 |
| Definitive Healthcare Corp. (DH)vs › | $104.26M | -1.60 | -2.42 | -1.68 | -1.45 |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.68M | -0.12 | -0.17 | -0.12 | -0.12 |
Trailing EPS (TTM)
$-3.50
Forward EPS (Est.)
$-1.83
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -4.40 |
| 2024-12-31 | -3.95 |
| 2023-12-31 | -2.65 |
| 2022-12-31 | -2.21 |
| 2021-12-31 | -21.92 |
| 2020-12-31 | -7.74 |
